Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.
about
Epithelial Anion Transport as Modulator of Chemokine SignalingRole of Sphingolipids in the Pathobiology of Lung InflammationSphingolipids as cell fate regulators in lung development and diseaseSecond-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-raftsA pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung diseaseMicrobial, host and xenobiotic diversity in the cystic fibrosis sputum metabolomePulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomographyAcquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.Role of Cigarette Smoke-Induced Aggresome Formation in Chronic Obstructive Pulmonary Disease-Emphysema PathogenesisCystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial InfectionsAnti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa.Correlation of apical fluid-regulating channel proteins with lung function in human COPD lungsCFTR regulates early pathogenesis of chronic obstructive lung disease in βENaC-overexpressing miceCritical role of CFTR-dependent lipid rafts in cigarette smoke-induced lung epithelial injury.Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysemaGBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa.Involvement of ceramide in cell death responses in the pulmonary circulation.Airway Exposure to E-Cigarette Vapors Impairs Autophagy and Induces Aggresome Formation.Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.Cigarette smoke and CFTR: implications in the pathogenesis of COPDNeutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controlsLipids in cystic fibrosis.The role of sphingolipids in respiratory disease.Functional Rescue of F508del-CFTR Using Small Molecule CorrectorsDual PDE3/4 and PDE4 inhibitors: novel treatments for COPD and other inflammatory airway diseases.Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections.Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway.Emerging pharmaceutical therapies for COPD.Nano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases.Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.Ceramide mediates lung fibrosis in cystic fibrosis.Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.Cigarette smoke induced autophagy-impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis.Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2.The yin and yang of cystic fibrosis transmembrane conductance regulator function: implications for chronic lung disease.Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.Cigarette Smoke Exposure Inhibits Bacterial Killing via TFEB-Mediated Autophagy Impairment and Resulting Phagocytosis Defect.Lactosylceramide-accumulation in lipid-rafts mediate aberrant-autophagy, inflammation and apoptosis in cigarette smoke induced emphysema.
P2860
Q26744381-6B90AE4D-37F0-4EC2-A309-27CD0237CF74Q26771956-425BFEE1-1F2E-4DB5-ABEA-F5DBD012E6E2Q28084945-18036199-D5F2-4B0C-B985-585DC5C3D090Q28544815-4D0F080D-EA77-45D8-BFE6-6985BA43F9A7Q28727685-D9019A2D-4863-4D19-B108-7CA5BD0F4CB4Q28829667-4A412DB8-0C95-4FA5-9A04-C66299725FECQ31133549-C6709145-299D-496B-B556-936737BD2E38Q33586131-0BEC03E2-EEE6-4BD7-A505-DE11B8B494A6Q33756886-09325CAE-1BF5-4345-8404-1381EF28C698Q33799668-9DF56D71-14E2-4226-A19B-48F5B4F51D81Q33811046-F07DC60A-2768-4637-ACF1-52DA9A2D5D44Q33900765-FBCFDA14-F0F1-4A0C-899A-1B166B5D6DF7Q34342508-D8104E76-7689-4E2F-BA2E-732C32723875Q34361842-85E46333-B412-4C32-B092-0ABD84449295Q34399667-C1D10F62-9BAC-4D31-948F-7DF9CE73E406Q35057070-61346D7D-1B96-4640-90F4-B5F0EF1F7F8CQ35083187-B43EDB0C-32C2-4DD2-B4EE-DF887CC909ECQ35228672-2A3D34F5-98C8-4891-B33B-226ED4845A7CQ35983863-8BA60280-D177-4626-8B10-2C82F9C6E0C8Q36554939-D35C47A9-4064-461E-A546-D493952BAD20Q37191286-B14D0D76-1C31-40E0-AD76-32CC046FBF7FQ37234904-C8371AAD-3826-49C6-AEF2-EEBEAEAB5337Q37248481-5CF12485-AD83-49B6-A234-4001CC71CF54Q37920895-9D63734A-600E-4118-A9CC-1F92042B1622Q37928817-AA42328E-C06B-4584-8DD5-7C24FD2654A6Q38051325-755CBA92-A13E-443B-910A-B9D714C76350Q38187182-E5D2945C-7152-44CD-B99E-3667DC57A7ABQ38522938-FA4F6AC7-D7E7-44F1-8EB8-9274633957B7Q38633253-5AD79978-3837-402F-A44F-5DE56BAADAC8Q38645203-C5D7232A-7B1D-40E9-B03E-6167CE4565FBQ38937131-88B44DA8-2273-4CE8-A295-84E02740A341Q39071592-731A749B-3157-4B3C-B705-7D220B49C989Q39884057-BBDB88F1-FF33-4B91-AAFC-0ADF4BBC43FBQ40048899-C2A2D308-AF12-4415-B071-7AEA0BB986FBQ40614221-171ABCA5-465E-4536-BB58-3BE0D8444F09Q41877292-033F1C75-46E2-4F81-907A-B9D8559695D0Q43249070-D4412FD3-7C36-4429-836B-07B16A03174EQ47231903-CDFBAE94-A57C-472C-9E70-78D1594DD1E6Q49733315-5B2F222A-119B-40EB-9CC9-897F2B5847C8Q51662730-8A35FB25-8077-498A-B833-57871DD24F26
P2860
Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Critical modifier role of memb ...... in lung injury and emphysema.
@ast
Critical modifier role of memb ...... in lung injury and emphysema.
@en
type
label
Critical modifier role of memb ...... in lung injury and emphysema.
@ast
Critical modifier role of memb ...... in lung injury and emphysema.
@en
prefLabel
Critical modifier role of memb ...... in lung injury and emphysema.
@ast
Critical modifier role of memb ...... in lung injury and emphysema.
@en
P2093
P2860
P356
P1476
Critical modifier role of memb ...... in lung injury and emphysema.
@en
P2093
Manish Bodas
Neeraj Vij
Steven Mazur
Taehong Min
P2860
P304
P356
10.4049/JIMMUNOL.1002850
P407
P577
2010-12-06T00:00:00Z